Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Tracking every penny for budgeting provides clarity and control over finances. This intro highlights the benefits and sets you up for smarter spending.
26,876 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Solana is slipping as broader crypto markets pull back, with traders weighing key support levels and evolving ETF flo...
A Solana-based DEX reports a $1.34 million loss tied to five legacy pools. The attacker used forged LP tokens, and fu...
In a volatile 2026 market, a defensively positioned dividend stock offers stock ultimate dividend safety. Coca-Cola i...
Taiwan Semiconductor's Q2 report is due July 16, shaping AI capex bets. Five stocks stand out as potential winners or...
Chord Energy reports strong 2025 results driven by Williston Basin efficiency, but investors question whether this wi...
A rapid-growth software startup markets a scrolling-based monetization model and seeks pre-IPO investors at $0.50 a s...
As the AI build-out accelerates, Marvell and Micron report results that highlight two distinct routes to profit: cust...
Eastman Chemical is delivering a steady 4.5% dividend as a new core catalyst reshapes its cash flow, turning the comp...
Over the past seven years, Chinese electric-vehicle and battery makers have channeled more than $100 billion into ove...
Iranian strikes have sharply reduced Qatar's LNG output, cutting roughly 17% of capacity and threatening global suppl...
A nationwide $1 million cap on home equity for Medicaid long-term care applicants will reshape eligibility rules and ...